Shares of OPKO Health Inc. (OPK) are soaring over 45% in pre-market today, after the company announced that its BioReference Laboratories is now accepting specimens for testing of coronavirus disease 2019 (COVID-19) from healthcare providers, clinics and health systems throughout the United States.
from RTT - Before the Bell https://ift.tt/2QeLyFj
via IFTTT
No comments:
Post a Comment